PORTSMOUTH, N.H., Jan. 21, 2019 /PRNewswire/ -- Darryl Williams, senior director of analytics at MediSpend, will discuss the value data analytics provides to strategic business decisions and compliance practices within the life sciences industry at the 2nd Annual CBI Data Analytics and Decisions Conference at 11:00 am on Wednesday, January 23, 2019 in Philadelphia, PA. The session, "Demonstrate the Value of Data Analytics to Improve Business" will explore various scenarios used to gain actionable insights from compliance data and other publicly available data sets.
"What many corporate decision makers fail to realize is that compliance monitoring results in a proliferation of data for an organization," said Williams. "This information can be analyzed to not only devise more effective compliance strategies but also to improve other areas of business practices."
"The integration of both industry and organizational data is a common challenge we see across life sciences companies," said Michaeline Daboul, ceo and co-founder of MediSpend. "Our customers have successfully addressed both business and technical challenges with our fully integrated solution suite which includes imbedded, real-time analytics dashboards."
The CBI conference provides an opportunity for life sciences organizations to determine best practices for integrating new technologies into their decision-making. Other topics expected to be covered at the event include the increased use of data in analyzing trends for fraud and identifying outliers and strengthening risk management and business intelligence for third-party data. Also, examining the different approaches to U.S. and global data sets and improving data remediation and validation will be top of mind, according to the event's website.
About MediSpend
MediSpend is a global leader in cloud-based compliance software for the life sciences industry. MediSpend is the compliance system of record for some of the world's largest life sciences companies. We help pharmaceutical, medical device, dental, and emerging biotech companies comply with global healthcare laws while reducing risk and lowering costs. The MediSpend Compliance Cloud enables life sciences companies to manage and monitor physician engagement, aggregate, and analyze enterprise data, and comply with global data privacy and transparency reporting regulations. Our employees are committed to customer success, innovation, and exceptional product development. Our customers are located in the United States, Europe, Asia, and Latin America. MMIS is headquartered in Portsmouth, N.H., with offices in Minnesota, New York City, and Phila, Pennsylvania.
Media Contact:
Kathy Fallon
kfallon@medispend.com
215-952-3223
SOURCE MediSpend
